Research Projects & Grants

  • Single Patient, Expanded Access. IND 162739, Role: PI, Status: Approved

For Profit Organization

  • A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy, Role: PI, Otsuka Pharmaceuticals, (05/2026 - 05/2027) Status: Approved
  • Listening to Patients: Building a Patient-Centered Outcomes Agenda for IgA Nephropathy, Role: PD/PI, Otsuka Pharmaceuticals, (12/2024 - 12/2026) Status: Awarded
  • Building a Patient-Centered Outcomes Agenda for IgA Nephropathy, Role: PI, Otsuka Pharmaceuticals, (03/2026) Status: Approved
  • CYTB323J12201: A Phase 2, Open-label, Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel in Patients Suffering with active, refractory Systemic Lupus Erythematosus (SLE) or Active, Refractory Lupus Nephritis (LN), Role: PI, Novartis Pharmaceuticals Corporation, (07/2026 - 07/2027) Status: Approved
  • A Phase 2/3, Multicenter, Open-label Trial to Evaluate the Long-term Safety, Tolerability, and Efficacy of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy, Role: PI, Otsuka Pharmaceuticals, (03/2026 - 03/2027) Status: Approved
  • A Phase 2, adaptive, randomized, open-label, assessor-blinded active-controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus Standard of Care in patients suffering from systemic lupus erythematosus (SLE) with active, refractory lupus nephritis (LN) Novartis protocol - CYTB323J12201, Role: PD/PI, Novartis Pharmaceuticals Corporation, (05/2025 - 12/2030) Status: Awarded

Internal

  • Echocardiographic Features and Genotypic Variations in Autosomal Dominant Polycystic Kidney Disease, Role: PI, LLU Dept. of Medicine, (06/2024) Status: Approved
  • HRQOL in Patients with Lupus Nephritis and IgA Nephropathy, Role: PI, LLU Dept. of Medicine, (12/2023) Status: Approved
  • Evaluation of PKD diagnosis impact on the patients' quality of life, Role: PI, LLU Dept. of Medicine, (11/2023) Status: Approved
  • Distress Tolerance in Lupus Nephritis; Exploring the Impact of Acceptance on Disease Severity, Role: PI, LLU Dept. of Medicine, (09/2023) Status: Approved
  • Cardiovascular risk management in lupus nephritis and IgA nephropathy patients, Role: PI, LLU Dept. of Medicine, (03/2023) Status: Approved
  • A multi-site glomerular diseases registry, Role: PI, LLU Dept. of Medicine, (03/2021) Status: Approved
  • Assessment of kidney disease in COVID-19 patients during hospitalization and post recovery, Role: PI, LLU Dept. of Medicine, (02/2021) Status: Approved
  • Personalized AI-Powered Education for Rare Glomerular Diseases and Polycystic Kidney Disease, Role: PI, LLU Dept. of Medicine, (02/2025) Status: Approved
  • Di-PKD: A Pilot Trial of a 12-Month Targeted Dietary Intervention on Cyst Progression in Patients with Autosomal Dominant Polycystic Kidney Disease, Role: Investigator, LLU Dept. of Medicine, (02/2025) Status: Approved
  • Gender and Socioeconomic Disparities in Cardiovascular Events Among Patients with Nephrotic Syndrome, Role: PI, LLU Dept. of Medicine, (03/2025) Status: Approved
  • Development and Validation of a Board-Style Nephrology Question Bank for GlomCon Online Glomerular Disease and PKD Fellowship Program and Loma Linda University Internal Medicine Residents, Role: PI, LLU Dept. of Medicine, (03/2026) Status: Approved
  • Loma Linda Polycystic Kidney Disease Registry, Role: PI, LLU Dept. of Medicine, (09/2025) Status: Approved
  • Evaluating how Genetic Testing Influences Clinical Decision Making Among Nephrologists, Role: PI, LLU Dept. of Medicine, (08/2026) Status: Approved

Non-Profit Organization

  • Online Glomerular Diseases Fellowship Program, Role: PD/PI, American Society of Nephrology, (07/2024 - 10/2026) Status: Awarded
  • Kidney Check: Proactive Urine Dipstick Testing in Healthy Individuals, Role: PD/PI, IgAN Foundation, (07/2025 - 06/2027) Status: Awarded
  • Kidney Check: Proactive Urine Dipstick Testing in Healthy Individuals, Role: PI, IgAN Foundation, (07/2025) Status: Approved